Context: The goal of phototherapy is to lower the concentration of circulating bilirubin or keep it from increasing in the treatment of neonatal unconjugated hyperbilirubinaemia. As phototherapy decrease billirubin level of infants, it is important to fix the dose of phototherapy. Objectives: The aim of the study was to compare the effectiveness of double phototherapy versus conventional single phototherapy in the treatment of neonatal unconjugated hyperbilirubinaemia. Materials and Methods: For this purpose 50 term and preterm newborns were enrolled. They were divided into 2 groups, 38 newborns were taken in group 1 and 12 newborn were taken in group 2. The babies who got conventional single phototherapy were taken in group 1. Each group was again divided into 3 subgroups according to their birth weight Normal Birth Weight (NBW), = Low Birth Weight (LBW) and Very Low Birth Weight (VLBW).
Introduction
Jaundice is the visible manifestation in skin and sclera of elevated serum concentration of bilirubin. Neonatal jaundice may not appear until serum bilirubin exceeds 5 to 7 mg / dl (Madan et al. 2005) . It is a commonly occurring condition that develops in 25-50% of term newborns and higher percentage infants (Martin and Cloherty 2004) . Traditionally, a distinction has been made between physiologic jaundice and hyperbilirubinaemia, which is either pathologic in origin or severe enough to be considered for further evaluation and intervention. The later entity has been called 'nonphysiologic' although frequently no disease is identified as being causative or consequent. Any total serum bilirubin (TSB) elevation exceeding 17 mg/dl (291 umol/1) should be considered pathologic and warrants investigations for a cause and possible therapeutic intervention (Madan et al. 2005) . Physiological jaundice is the commonest causes of neonatal jaundice. This is a transient unconjugated hyperbilirubinaemia in the neonatal period. Though neonatal hyperbilirubinaemia (NH) is not a major cause of mortality in our country but is observed during neonatal period, infancy or childhood. NH is a cause of concern for the parents, and paediatricians as well. It occurs in 5 -10 % of healthy term infants (Singhal et al. 1992) . NH is the most common reason of readmission after early hospital discharge. Concerns regarding jaundice have increased after report of bilirubin induced brain damage occurring in healthy term infants even without haemolysis (Penn et al. 1994, Maisels and Newman 1995) .
Neonatal jaundice occurred more often among East Asian and mixed Asian/white infants than among white infants. However, the risk of jaundice requiring extended hospital stay, rehospitalisation, phototherapy, or blood transfusion was elevated only for infants of full East Asian parentage (Setia et al. 2002) . Subcommittee on hyperbilirubinaemia of the American Academy of Paediatrics (AAP 2004) gave some guidelines for the prevention of neonatal hyperbilirubinaemia. These guidelines provide 10 recommendations and the last one describes 'Treat newborns, when indicated, with phototherapy or exchange transfusion'. Total serum bilirubin (TSB) in infant discharged within 48 h of age generally shows an increasing trend and some of these infants later develop hyperbilirubinaemia. In a cohort of 500 healthy term infants, Alpay et al. (2000) found that hyperbilirubinaemia (serum bilirubin> 17 mg/dl) commonly occurred after 72 h of age. As phototherapy decrease billirubin level of infants, it is important to fix the dose of phototherapy. Therefore the present study was undertaken to compare the effectiveness of double phototherapy versus conventional single phototherapy in the treatment of neonatal unconjugated hyperbilirubinaemia.
Materials and Methods
Subject, design and sample: Fifty term and preterm newborns were included from Neonatal unit, Department of Paediatrics and Department of Gynaecology, Chattagram Maa O Shisu General Hospital (CMSOGH) for the study. Total subject 50 (35 male, 15 female) which was divided into 2 groups; I) newborns who got conventional single phototherapy 38 subjects (28 male, 10 female), and II) newborns who got conventional double phototherapy 12 subjects (7 male, 5 female). Each group was again divided into 3 subgroups according to their birth weight; A= Normal Birth Weight (NBW), n = 26; B= Low Birth Weight (LBW), n = 13; and C= Very Low Birth Weight (VLBW), n = 11. All the subjects were matched according to age, sex, birth weight and gestational age of the newborn. Two ml of blood was collected from superficial vein of each subject. TSB was measured daily during phototherapy until it comes down the normal level. Age and weight were recorded in a data collection sheet.
Laboratory Investigations and phototherapy: TSB of newborn was measured from venous blood using Mod. Jendrassik and Grof's Method by an analyzer. Newborns with TSB level > 17mg/dl after 72 hours of life was defined to have significant hyperbilirubinaemia. Single or double phototherapy was selected depending upon the availability of phototherapy device in neonatal unit. Selection of double phototherapy preferably given when serum bilirubin in NBW is > 16 mg/ dl, in LBW > 14 mg/ dl and in VLBW > 12 mg/ dl. In conventional single phototherapy, 5 fluorescent white tube light of 40 watts each with wave length of 450 nm were used at a distance of 45 cm from body surface. In double phototherapy, high radiance used under surface of the body and conventional single phototherapy given from above.
Ethical Consideration and data analysis: Informed parental consent was taken before enrolling the baby into the study. The procedure was fully explained to the parents and they were informed that the study would not hamper the treatment of the baby. Permission was also taken from the concerned departmental ethical committee in order to perform the study.
Analysis was done by employing Statistical Package for Social Science (SPSS Version 10.0) software package. Data were expressed as mean ± SD and percentage. To compare mean values between groups, ttest was done as appropriate; P < 0.05 was considered as minimum level of significance.
Results
Out of 50 enrolled newborn, 38 were in group I and 12 were in group II. Males were 70% of total subjects, where 56% were in group I and 14% in group II. The reaming 30% females were distributed as 20% in group I and 10% in group II. The distributions of birth weights of enrolled neonates were NBW 52%, where 38% in group I and 14% in group II; LBW 26% where 16% in group I and 10% in group II; and VLBW were 22%, all in group I (Table 1) . According to gestational age of newborn babies, preterm were 16 (32%) where, 30% were in group I and 2% in group II. Term babies were 34 (68%), where 46% were in group I and 22% in group II. The serum bilirubin level of preterm babies was 13.17 ± 1.49 mg/dl and in term babies it was 17.32 4.08 mg/dl ( Table 2 ). The neonatal hyperbilirubinaemia was due to physiologic Jaundice in 38% cases, neonatal sepsis in 50% cases and perinatal asphyxia in 50% cases ± The TSB level was 18.47 5.38 mg/dl in physiological jaundice, 14.90 ± ± 1.45 mg/dl in neonatal sepsis and 14.10 1.47 mg/dl in perinatal asphyxia (Table 2 ). In NBW babies, TSB levels before and after phototherapy were found 19.5 2.9 and 13.4 2.4 mg/dl respectively (p<0.001) in conventional single phototherapy with decline rate of 0.19 ± 0.10 mg/dl/h and 4.58 ± ± ± ± 2.43 mg/dl/day. In conventional double phototherapy, TSB levels before and after phototherapy was 26.4 ± 5.5 and 13.1 ± 3.4 mg/dl respectively (p<0.001) with decline rate of 0.26 ± 0.09 mg/dl/h and 6.27 ± 2.26 mg/dl/day, which was highly significant (p <0.001) in both cases. The decline rate of serum bilirubin was higher in conventional double phototherapy than conventional single phototherapy (Table 3) . In LBW babies, TSB levels before and after phototherapy was found 16.1 1.75 and 12.7 1.26 mg/dl respectively in conventional single phototherapy having decline rate of 0.09 0.03 mg/dl/h and 2.07 ± ± ± ± 0.84 mg/dl/day. In conventional double phototherapy, TSB levels before and after phototherapy was 23.3 ± 3.46 and 13.96 ± 2.07 mg/dl respectively having decline rate of 0.20 0.08 mg/dl/h and 4.70 2.08 mg/dl/day. It was highly significant (p<0.001) in case of conventional double phototherapy but it was not significant for conventional single phototherapy (Table 3) , In VLBW babies, TSB before and after phototherapy was 13.47 ± ± ± 1.87 and 9.28 ± 1.81 mg/dl respectively for conventional single phototherapy (P<0.001) with decline rate of 0.09 ± 0.07 mg/dl/h and 2.24 1.10 mg/dl/day. Any VLBW baby who was given conventional double phototherapy was not found (Table 3) . Neonatal jau combined with increased turnover of red cells. Pathologic conditions that can increase bilirubin production include isoimmunization, heritable hemolytic disorders, and extravasated blood (e.g., from bruises and cephalhematomas) (Maisels 2005) . The goal of therapy is to lower the concentration of circulating bilirubin or keep it from increasing. Phototherapy achieves this by using light energy to change the shape and structure of bilirubin, converting it to molecules that can be excreted even when normal conjugation is deficient (Lightner and McDonagh 1984) . Absorption of light by dermal and subcutaneous bilirubin induces a fraction of the pigment to undergo several photochemical reactions that occur at very different rates. These reactions generate yellow stereoisomers of bilirubin and colourless derivatives of lower molecular weight (Maisels and McDonagh 2008) . The products are less lipophilic than bilirubin, and unlike bilirubin, they can be excreted in bile or urine without the need for conjugation. The relative contributions of the various reactions to the overall elimination of bilirubin are unknown, although in vitro and in vivo studies suggest that photoisomerization is more important than photodegradation (Lightner and McDonagh 1984) . Bilirubin elimination depends on the rates of formation as well as the rates of clearance of the photoproducts. Photoisomerization occurs rapidly during phototherapy, and isomers appear in the blood long before the level of plasma bilirubin begins to decline (Maisels and McDonagh 2008) .
±
Phototherapy is now widely accepted as detoxifies bilirubin and facilitates its excretion by the kidneys. In term infants, double phototherapy with a fiber-optic blanket has been reported to be more effective in reducing bilirubin than conventional phototherapy (Nuntnarumit 2002) . In this study, male were 70% and female were 30%. Here percentage of male is greater than female. This is supported by the study of Lewis et al. (1982) , where male remain jaundiced for significantly higher than female.
In a previous study (Rashid et al. 2003), preter 13.17 ± 1.49 mg/dl and in term babies it was 17.32 ± 4.08 mg/dl respectively which is almost similar to the study done by William and Cashore (1980) . In preterm neonates double phototherapy is more effective than single phototherapy (Kang and Shankaran 1995) . Rashid et al. (2003) observed NH due 26.03%, physiologic jaundice 19.95% and perinatal asphyxia 16.52%. In the present study, the percentages are higher, because in their study they considered many complications like sepsis, pneumonia, meningitis, premature babies, neonatal jaundice, and birth asphyxia. Zahedpasha et al. (2006) studied 19.70 ± 1.60 mg/dl TSB level in single phototherapy which is similar to the present study but in double phototherapy the bilirubin level was 20.3 ± 2.4 mg/dl which is lower than this study. In this study only three NBW neonates were found which had bilirubin level >30.0 mg/dl. Decline rate of TSB in conventional single and double phototherapy suggests that phototherapy is an important therapeutic method for NBW neonates and double phototherapy seems to be a better therapeutic approach than single phototherapy. This result is almost alike to the study of Payon et al. (2008) , who found that the decline rate of serum bilirubin in conventional single and double phototherapy was 3.50 ± 1.70 mg/dl/day and 5.40 ± 2.00 mg/dl/day. This result is supported by other studies (Kang and Shankaran 1995 , Maisels 2006 ). In VLBW neonates, the decline rate of serum bilirubin was found 0.09 ± 0.07 mg/dl/hr and 2.24 ± 1.10 mg/dl/day with conventional single phototherapy which is consistent with s dy of tu Maisels (2006) . The decline rate was slower in VLBW neonates compared to NB W and higher than LBW.
Conclusions
From this above discussion it can be concluded that double phototherapy is more effective than conventional rapy in the treatment of neonatal hyperbilirubinaemia in both groups of neonates; however the single photothe rate of fall of bilirubin was higher in NBW subgroups.
